Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Immunological Methods|January 3, 2013
Immobilized carboxymethylated dextran coatings for enhanced ELISABenoît Liberelle, Abderrazzak Merzouki, Gregory De Crescenzo
Journal of Biochemistry and Molecular Biology|December 10, 2002
Identification and characterization of a putative baculoviral transcriptional factor IE-1 from Choristoneura fumiferana granulovirusKianoush Khajeh Rashidan, Nasha Nassoury, Abderrazzak Merzouki, et al.
International Journal of Nanomedicine|October 20, 2010
Chitosanase-based method for RNA isolation from cells transfected with chitosan/siRNA nanocomplexes for real-time RT-PCR in gene silencingMohamad Alameh, Myriam Jean, Diogo Dejesus, et al.
Advanced Drug Delivery Reviews|July 23, 2013
Chitosans for delivery of nucleic acidsMichael D Buschmann, Abderrazzak Merzouki, Marc Lavertu, et al.
Virus Genes|September 11, 2002
Molecular characterization of three new avian infectious bronchitis virus (IBV) strains isolated in QuebecRidha Smati, Amer Silim, Claude Guertin, et al.
Biomaterials|April 1, 2011
Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexesMarc Thibault, Mélina Astolfi, Nicolas Tran-Khanh, et al.
Journal of Immunological Methods|September 28, 2010
New ELISA approach based on coiled-coil interactionsBenoît Liberelle, Laurence Bartholin, Cyril Boucher, et al.
International Journal of Nanomedicine|March 30, 2012
Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide deliveryMohamad Alameh, Diogo Dejesus, Myriam Jean, et al.
Anticancer Research|October 13, 2012
Adva-27a, a novel podophyllotoxin derivative found to be effective against multidrug resistant human cancer cellsAbderrazzak Merzouki, Michael D Buschmann, Myriam Jean, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 17, 2011
Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetesMyriam Jean, Mohamad Alameh, Diogo De Jesus, et al.
Pageof 1